ConductScience.org, home

Paper175277

Management of ovarian carcinoma. Current concepts and future prospects.

Tobias JS and 1 other. N Engl J Med, 1976. Cited by 118 papers, by iCite.

Cite this record

ConductScience Library. Management of ovarian carcinoma. Current concepts and future prospects. Papers, record 175277. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/175277

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Management of ovarian carcinoma. Current concepts and future prospects.
PubMed
Journal
N Engl J Med
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
118
iCite
Relative citation ratio, by iCite
6.83
iCite
Revised in PubMed
2004-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tobias JSJ S
2Griffiths CTC T

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ovarian NeoplasmsMajor topic
Adenocarcinoma, Mucinous
Alkylating Agents
Antimetabolites, Antineoplastic
Carcinoma
Cystadenocarcinoma
Drug Therapy, Combination
Female
Humans
Progestins

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.

PMIDTitleJournalYearIn PapersSource
12132048Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients.Bone Marrow Transplant2002https://conductscience.org/library/papers/12132048PubMed
6625665A study of the treatment of ovarian carcinoma.Arch Gynecol1983https://conductscience.org/library/papers/6625665PubMed
6371017Chemotherapy in advanced ovarian cancer.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6371017PubMed
6371015Developing new drugs for ovarian cancer: a challenging task in a changing reality.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6371015PubMed
6357333Radiation therapy in the treatment of patients with cancer of the ovary.Bull N Y Acad Med1983https://conductscience.org/library/papers/6357333PubMed
6321729Hormonal aspects of ovarian malignancy.J R Soc Med1984https://conductscience.org/library/papers/6321729PubMed
3543533The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.Med Oncol Tumor Pharmacother1986https://conductscience.org/library/papers/3543533PubMed
2491962Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2491962PubMed
121890Chemotherapy in the management of ovarian carcinoma: a review.J R Soc Med1979https://conductscience.org/library/papers/121890PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/175277

GET https://conductscience.org/api/papers/v1/175277/authors